Skip to main content
. 2012 Feb 23;9(3):235–242. doi: 10.3109/15412555.2011.650243

Table 3.

Annual changes in thoracic vertebral BMD, lung function, and LAA%

Exacerbation (−) p-value (within group) Exacerbation (+) p -value (within group) p-value (between groups)
BMD, mg/ml −0.30 (−1.82, 1.33) 0.41 −3.78 (−5.81, −0.29) 0.002 0.01
BMD/base, % −0.60 (−3.07, 2.63) 0.39 −5.41 (−10.6, −0.36) 0.002 0.02
BMI 0.00 (−0.53, 0.38) 0.65 −0.78 (−1.49, 0.70) 0.34 0.38
FEV1, mL −51.4 (−117.0, −7.7) 0.0001 −75.0 (−97.9, −4.7) 0.0005 0.72
%FEV1, % 0.28 (−2.08,2.15) 0.74 0.00 (−1.72, 1.58) 0.91 0.85
DLCO /VA, mL/min/mmHg/L −0.13 (−0.32, 0.03) 0.01 −0.15 (−0.26, 0.03) 0.10 1.00
LAA% (−960), % 0.12 (−0.61, 1.27) 0.43 1.32 (−4.78, 1.31) 0.0005 0.01
PaO2, mmHg −0.48 (−2.42, 1.80) 0.91 −1.00 (−4.78, 1.32) 0.20 0.29

Data are expressed as the median (25th, 75th percentile). BMD, bone mineral density in thoracic vertebrae ; BMD/base, percentage change in BMD compared with baseline BMD; FEV1, forced expiratory volume in 1 second; %FEV1, FEV1 % predicted DLCO /VA, ratio of diffusing capacity to alveolar ventilation; LAA%, percentage of low attenuation area.